# Study State Tracking - IRON DEFICIENCY WITHOUT ANEMIA STUDY

## Study Complete ✓

**Date Completed**: 2026-01-31  
**Study Directory**: `studies/iron-deficiency-women-2026-01-31/`  
**Status**: ALL PHASES COMPLETED

---

## Phase Status

| Phase | Status | Iteration | Quality Gate Met | Notes |
|-------|--------|-----------|------------------|-------|
| Literature Review | ✓ COMPLETED | 1 | Yes | 30+ references synthesized |
| Research Plan | ✓ COMPLETED | 1 | Yes | All hypotheses defined |
| Methods | ✓ COMPLETED | 1 | Yes | Complete documentation |
| Analysis | ✓ COMPLETED | 1 | Yes | All scripts executed |
| Synthesis | ✓ COMPLETED | 1 | Yes | Discussion & conclusion done |
| Manuscript | ✓ COMPLETED | 1 | Yes | LaTeX manuscript ready |
| GitHub Publication | READY | 0 | N/A | Ready for publication |

## Quality Gates - All Passed ✓

- ✓ Literature: 30+ peer-reviewed references
- ✓ Research Plan: Clear, testable hypotheses
- ✓ Methods: NHANES survey weighting documented
- ✓ Analysis: Reproducible Python scripts
- ✓ Tables: 4 publication-quality LaTeX tables
- ✓ Figures: 4 publication-quality 300 DPI PNGs
- ✓ Synthesis: Comprehensive discussion (~2,800 words)
- ✓ Manuscript: ~8-10 pages, all sections complete

---

## Final Study Statistics

### Sample
- **Total participants**: 6,125 non-pregnant women aged 18-45
- **IDWA cases**: 580 (9.5%)
- **Iron supplement users**: 1,018 (16.6%)
- **Data source**: NHANES 2005-2022 (8 cycles)

### Key Findings
- **IDWA Prevalence**: 9.0% weighted (95% CI: 8.3%-9.7%)
- **Supplement Effect**: 6.4% higher ferritin in users (β=0.062, p=0.048)
- **Optimal Dose**: Moderate (18-27 mg/day) showed strongest effect (β=0.207, p<0.001)
- **Highest Risk**: Mexican American women (11.6% IDWA)

### Deliverables Summary
| Category | Count | Location |
|----------|-------|----------|
| Literature files | 3 | `01-literature/` |
| Research plan files | 5 | `02-research-plan/` |
| Methods files | 7 | `03-methods/` |
| Analysis scripts | 5 | `04-analysis/scripts/` |
| Tables | 4 | `04-analysis/outputs/tables/` |
| Figures | 4 | `04-analysis/outputs/figures/` |
| Synthesis files | 5 | `05-conclusion/` |
| Manuscript files | 6 | `manuscript/` |
| **TOTAL** | **39+** | All phases |

---

## Data Sources Used
- **FERTIN** (Ferritin): D, E, F, I, J cycles
- **FETIB** (Iron/TIBC): D, J cycles
- **CBC** (Complete Blood Count): D, E, F, G, H, I, J, L cycles
- **DEMO** (Demographics): All cycles B-L
- **DSQTOT** (Dietary Supplements): E, F, G, H, I, J, L cycles
- **BMX** (Body Measures): All cycles
- **FASTQX** (Fasting): All cycles

## Key Variables
- **Ferritin**: LBXFER (ng/mL)
- **Hemoglobin**: LBXHGB (g/dL)
- **Iron**: LBXIRN (µg/dL)
- **TIBC**: LBXTIB (µg/dL)
- **Transferrin Saturation**: LBDPCT (%)
- **Supplement Iron**: DSQTIRON (mg)
- **Survey Weight**: WTMEC2YR

## Study Definition
- **Population**: Non-pregnant women aged 18-45
- **IDWA**: Ferritin <15 ng/mL AND Hemoglobin ≥12 g/dL
- **Primary Outcome**: Log-transformed ferritin
- **Primary Predictor**: Iron supplement use

## Publications Target
- American Journal of Clinical Nutrition
- British Journal of Nutrition
- Nutrients
- Journal of Nutrition

---

**Study Ready for Publication**
